GREN yields 20000000.00% · PFE yields 6.20%● Live data
📍 GREN pulled ahead of the other in Year 1
Combined, GREN + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GREN + PFE for your $10,000?
In June 2003, AgroCan Corporation changed its name to Greensmart Corporation in connection with an asset acquisition agreement with Winsmart Development, Ltd. According to the basic terms of the agreement, the company would issue to Winsmart 29,868,737 shares of its common stock. Also, Winsmart would sell to the company approximately 553,212 young eucalyptus trees planted in a total of 340 leased hectares; and a tree seedling and nursery farm situated on 3.3 leased hectares. Greensmart Corporation, through its subsidiary, AgroCan (China), Inc., specializes in producing compound fertilizers, which are custom-made to suit local conditions, such as plant, soil, and climate. Compound fertilizers are the end product made from the combination of the three primary nutrients: nitrogen, phosphate, and potassium, together with other elements, such as iron, zinc, copper, and manganese. These elements are blended in different proportions, and are made into pellets and packed into bags. Fertilizer applications include mainly paddy rice, wheat, corn, sugar cane, tobacco, cotton, vegetables, tree plantation, and fruit trees. The company's fertilizers are sold under the brand name 'AgroCan Three Leaves'. Its main customers for the fertilizers comprise the farming supply bureaus and cooperatives under the State Internal Trade Bureau of the People's Republic of China. These entities act as wholesalers to individual farmers. State-owned farms and plantations are also major accounts of the company. Greensmart Corporation was founded in 1996 and is based in Kwun Tong, Hong Kong.
Full GREN Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.